Compare Ginkgo Bioworks Holdings Inc (DNA) vs SAP SE (SAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs SAP SE — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while SAP SE trades at $206.82 (market cap $240.81B). The key difference: SAP SE is far larger — about 476.2× Ginkgo Bioworks Holdings Inc's market cap, and SAP SE pays a 1.4% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | SAP | |
|---|---|---|
Market Cap | $505.73M | $240.81B |
Sector | Health | Technology |
52-Week High | $16.14 | $280.46 |
52-Week Low | $5.48 | $146.38 |
Enterprise Value | $607.68M | $239.52B |
Dividend Yield | — | 1.4% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About SAP SE
Founded in 1972 by former IBM employees, SAP provides database technology and enterprise resource planning software to enterprises around the world. Across more than 180 countries, the company serves 440,000 customers, approximately 80% of which are small to medium-size enterprises.
Read more on SAP →
